The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aldomet Film-coated Tablets 250 mg

250 mg milligram(s) Coated tablet

Aspen Pharma Trading LimitedPA1691/012/001

Main Information

Trade NameAldomet Film-coated Tablets 250 mg
Active SubstancesMethyldopa
Strength250 mg milligram(s)
Dosage FormCoated tablet
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/012/001

Group Information

ATC CodeC02AB Methyldopa
C02AB01 methyldopa (levorotatory)

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1979
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back